BIO

Bio Rad
NYSE

Real-time Quotes | Nasdaq Last Sale

477.66
-0.38
-0.08%
After Hours: 477.66 0 0.00% 16:06 07/10 EDT
OPEN
479.97
PREV CLOSE
478.04
HIGH
479.97
LOW
473.00
VOLUME
229.74K
TURNOVER
--
52 WEEK HIGH
497.42
52 WEEK LOW
303.82
MARKET CAP
11.74B
P/E (TTM)
9.16
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BIO stock price target is 517.50 with a high estimate of 525.00 and a low estimate of 495.00.

EPS

BIO News

More
Biomarin's Hemophilia A Drug Among 5 Up for FDA Approval Soon
GuruFocus.com · 1d ago
Bio-Rad (BIO) Banks on Coronavirus PCR Tests Amid Cost Woes
Zacks · 1d ago
3 Health Care Companies That Beat the Market in the 1st Half of the Year
GuruFocus screener identifies top performers amid coronavirus pandemic Continue reading...
GuruFocus.com · 06/30 21:18
Bio-Rad Rides on PCR Test Kits for Coronavirus Amid Cost Woe
Zacks · 06/30 15:40
Biotech IPOs are booming -- but it's not all about Covid-19
CNN.com · 06/25 12:43
Moderna, Other Vaccine Developers Lead The Way In New GERM ETF
Vaccines are all the rage these days, both in the medical and investment fields. Now, there's an exchange-traded fund for that.
Benzinga · 06/19 12:55
New GERM ETF focuses on biotech for infectious diseases
Seeking Alpha - Article · 06/18 14:13
IPO Update: Genetron Holdings Files Proposed IPO Terms
Seeking Alpha - Article · 06/16 17:12

Industry

Medical Equipment, Supplies & Distribution
-0.13%
Healthcare Equipment & Supplies
-0.35%

Hot Stocks

Symbol
Price
%Change

About BIO

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.
More

Webull offers kinds of Bio-Rad Laboratories, Inc. stock information, including NYSE:BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.